div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader039fdokumencomreader039viewer20230513126341a044b3709551f30a7281html5page1jpg target=_blank amp-img class=trans-thumb alt=Page 1: A Phase I study of AMGN-0007 a recombinant osteoprotegerin construct in patients with multiple myeloma or breast carcinoma related bone metastases src=https:reader039fdokumencomreader039viewer20230513126341a044b3709551f30a7281html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader039fdokumencomreader039viewer20230513126341a044b3709551f30a7281html5page2jpg target=_blank amp-img class=trans-thumb alt=Page 2: A Phase I study of AMGN-0007 a recombinant osteoprotegerin construct in patients with multiple myeloma or breast carcinoma related bone metastases src=https:reader039fdokumencomreader039viewer20230513126341a044b3709551f30a7281html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader039fdokumencomreader039viewer20230513126341a044b3709551f30a7281html5page3jpg target=_blank amp-img class=trans-thumb alt=Page 3: A Phase I study of AMGN-0007 a recombinant osteoprotegerin construct in patients with multiple myeloma or breast carcinoma related bone metastases src=https:reader039fdokumencomreader039viewer20230513126341a044b3709551f30a7281html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader039fdokumencomreader039viewer20230513126341a044b3709551f30a7281html5page4jpg target=_blank amp-img class=trans-thumb alt=Page 4: A Phase I study of AMGN-0007 a recombinant osteoprotegerin construct in patients with multiple myeloma or breast carcinoma related bone metastases src=https:reader039fdokumencomreader039viewer20230513126341a044b3709551f30a7281html5thumbnails4jpg width=142...